Skip to main content

Table 2 Genotype distribution in cases and controls of the eligible studies

From: Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls

First author

Year

Cases

Controls

HWE in controls

MAF (cases/controls)

GG

GA

AA

GG

GA

AA

Maillet P [45]

2000

34

13

0

120

40

3

0.874

0.138 / 0.141

Dork T [34]

2001

753

235

12

422

74

4

0.705

0.130 / 0.082

Sommer SS [17]

2002

38

5

0

32

11

0

0.336

0.058 / 0.128

Angele S [33]

2003

240

65

7

192

56

6

0.433

0.127 / 0.134

Bretsky P [22]

2003

335c

 

47

329c

 

47

NA

NA

Angele S [53]

2004

457

153

18

309

124

12

0.917

0.150 / 0.166

Buchholz TA [37]

2004

39

17

2

394

119

15

0.107

0.181 / 0.141

Kristensen AT [46]

2004

99

50

2

2413

1008

105

0.983

0.179 / 0.173

Heikkinen K [35]

2005

68

44

9

174

109

23

0.308

0.256 / 0.253

Landi S [47]

2006

205

73

7

238

63

3

0.602

0.153 / 0.113

Renwick A [36]

2006

339

98

6

371

131

19

0.088

0.124 / 0.162

Tommiska J a [29]

2006

485

285

33

404

260

38

0.648

0.219 / 0.239

Tommiska J b [29]

2006

469

276

33

404

260

38

0.648

0.220 / 0.239

Wu X [48]

2006

434

156

18

439

136

17

0.109

0.158 / 0.144

Yang H [21]

2007

537c

 

7

536c

 

10

0.590

NA

Gonzalez-Hormazabal P [18]

2008

100

26

0

174

26

0

0.326

0.103 / 0.065

Hirsch AE [23]

2008

29c

 

8

78c

 

17

NA

NA

Margulis V [54]

2008

254

64

5

249

81

5

0.583

0.115 / 0.136

Schrauder M [32]

2008

406

99

9

369

129

13

0.668

0.114 / 0.152

Tapia T [31]

2008

74

19

1

183

15

2

0.015

0.112 / 0.048

Akulevich NM a [30]

2009

95

25

2

138

53

7

0.501

0.119 / 0.169

Akulevich NM b [30]

2009

105

24

3

293

90

15

0.020

0.114 / 0.151

Li D [52]

2009

524

186

18

565

200

8

0.034

0.152 / 0.140

Oliveira S [43]

2011

113

31

5

194

79

7

0.755

0.138 / 0.166

Al-Hadyan KS [49]

2012

131

23

2

218

33

0

0.265

0.087 / 0.066

Xu L a [24]

2012

239

64d

 

392

119d

 

> 0.05

NA

Xu L b [24]

2012

244

45d

 

305

69d

 

> 0.05

NA

Alsbeih G [42]

2013

90

8

2

88

12

0

0.523

0.060 / 0.060

Pena-Chilet M [50]

2013

349

91

9

232

68

11

0.040

0.121 / 0.145

Calderon-Zuniga Fdel C [20]

2014

82

12

0

96

0

0

NA

0.060 / 0.000

Damiola F [39]

2014

63

6

1

177

66

7

0.778

0.057 / 0.160

Wojcicka A [38]

2014

1261

319

23

1455

357

32

0.066

0.114 / 0.114

Maillard S [19]

2015

164

11

0

262

8

0

0.805

0.031 / 0.015

Pereda CM [41]

2015

153

44

0

162

42

2

0.690

0.112 / 0.112

Tecza K [51]

2015

153

64

6

254

76

5

0.800

0.170 / 0.128

Halkova T [40]

2016

158

45

5

284

81

9

0.270

0.132 / 0.132

Al-Harbi NM [44]

2017

201

28

3

275

38

0

0.253

0.073 / 0.061

  1. HWE, hardy-weinberg equilibrium; MAF, minor allele frequency; NA, data was unavailable
  2. a,bTwo independent case-control studies were presented for the same original study
  3. cnumber of GG + GA
  4. dnumber of GA + AA